Alkermes plc (Nasdaq: ALKS) today announced the presentation of research related to its psychiatry franchise ...
Alkermes plc ALKS has made steady progress with its portfolio of proprietary products — Vivitrol (alcohol and opioid dependence), Aristada (schizophrenia) and Lybalvi (schizophrenia and bipolar ...
Curious to know if your medication could be affecting your weight? Here’s a look at how 12 types of medicine might impact ...
Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility ...